US Stock MarketDetailed Quotes

AADI Aadi Biosciences

Watchlist

2.110
-0.040-1.86%

Close Oct 18 16:00 ET

2.110
0.0000.00%

Post 20:02 ET

51.94MMarket Cap-868P/E (TTM)

Aadi Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

45.36%-9.16M

7.78%-19.65M

-20.19%-59.66M

14.73%-9.64M

-45.83%-11.95M

-56.32%-16.76M

-9.76%-21.31M

-121.38%-49.64M

9.00%-11.31M

52.83%-8.2M

Net income from continuing operations

18.85%-14.58M

-20.14%-18.29M

-8.68%-65.77M

-16.93%-16.27M

-12.63%-16.3M

1.63%-17.97M

-9.86%-15.22M

45.03%-60.51M

12.99%-13.91M

83.38%-14.47M

Depreciation and amortization

13.95%49K

31.58%50K

6.29%169K

-4.35%44K

266.67%44K

59.26%43K

-48.65%38K

51.43%159K

-36.11%46K

-58.62%12K

Other non cash items

0.00%115K

-0.57%173K

35.86%519K

2.68%115K

5,850.00%115K

-22.30%115K

40.32%174K

-54.31%382K

-5.88%112K

-101.13%-2K

Change In working capital

347.14%2.81M

39.35%-4.75M

-87.03%-3.4M

499.22%3.84M

-52.72%1.73M

-180.35%-1.14M

-4.01%-7.84M

-114.86%-1.82M

-67.76%641K

174.47%3.66M

-Change in receivables

-152.25%-987K

114.99%555K

-94.74%-3.63M

-42.61%229K

-930.81%-2.04M

192.87%1.89M

-36.74%-3.7M

-113.16%-1.86M

--399K

---198K

-Change in inventory

-127.93%-162K

125.23%490K

-75.44%-3.27M

-97.43%-2.23M

4,700.00%322K

210.48%580K

-861.39%-1.94M

---1.86M

---1.13M

---7K

-Change in prepaid assets

-0.87%1.47M

248.44%953K

346.27%3.6M

794.78%1.03M

264.04%1.73M

2,603.64%1.49M

-10.88%-642K

32.46%-1.46M

107.01%115K

-153.98%-1.05M

-Change in payables and accrued expense

148.73%2.5M

-338.08%-6.76M

-104.10%-132K

269.53%4.82M

-65.73%1.72M

-603.54%-5.13M

62.61%-1.54M

-61.16%3.22M

-62.01%1.3M

38.25%5.03M

-Change in other current assets

-27.67%115K

18.97%138K

18.54%518K

66.67%120K

51.85%123K

0.00%159K

-7.20%116K

-9.15%437K

41.18%72K

-81.16%81K

-Change in other current liabilities

-1.59%-128K

-1.61%-126K

-72.51%-502K

-4.96%-127K

33.86%-125K

-300.00%-126K

-181.82%-124K

96.58%-291K

-182.31%-121K

97.79%-189K

Cash from discontinued investing activities

Operating cash flow

45.36%-9.16M

7.78%-19.65M

-20.19%-59.66M

14.73%-9.64M

-45.83%-11.95M

-56.32%-16.76M

-9.76%-21.31M

-121.38%-49.64M

9.00%-11.31M

52.83%-8.2M

Investing cash flow

Cash flow from continuing investing activities

-107.06%-3.57M

-35.36%10.56M

162.61%83.21M

104.32%3.65M

126.26%12.67M

21,079.67%50.56M

71,095.65%16.33M

-628.31%-132.89M

-183,332.61%-84.38M

-290.26%-48.24M

Net PPE purchase and sale

21.48%-541K

46.02%-739K

-794.59%-3.97M

-946.15%-816K

-976.47%-1.1M

-185.89%-689K

-5,852.17%-1.37M

-865.22%-444K

-69.57%-78K

---102K

Net investment purchase and sale

-105.91%-3.03M

-36.18%11.29M

165.82%87.18M

105.30%4.47M

128.59%13.77M

--51.25M

--17.7M

---132.44M

---84.3M

---48.14M

Cash from discontinued investing activities

Investing cash flow

-107.06%-3.57M

-35.36%10.56M

162.61%83.21M

104.32%3.65M

126.26%12.67M

21,079.67%50.56M

71,095.65%16.33M

-628.31%-132.89M

-183,332.61%-84.38M

-290.26%-48.24M

Financing cash flow

Cash flow from continuing financing activities

-72.20%87K

-225.00%-10K

-99.55%326K

174.77%80K

-100.10%-75K

459.77%313K

-97.32%8K

-48.79%72.62M

-221.59%-107K

-48.83%72.52M

Net common stock issuance

----

--0

----

-53.23%72.5M

--0

----

Proceeds from stock option exercised by employees

-74.03%94K

--0

-37.61%486K

-65.35%114K

-87.50%2K

166.18%362K

-97.32%8K

-6.48%779K

273.86%329K

-97.85%16K

Net other financing activities

---7K

---10K

75.72%-160K

92.20%-34K

---77K

----

93.15%-659K

---436K

--0

Cash from discontinued financing activities

Financing cash flow

-72.20%87K

-225.00%-10K

-99.55%326K

174.77%80K

-100.10%-75K

459.77%313K

-97.32%8K

-48.79%72.62M

-221.59%-107K

-48.83%72.52M

Net cash flow

Beginning cash position

57.85%53.84M

61.07%62.95M

-73.77%39.08M

-48.94%68.87M

-42.57%68.23M

-73.73%34.11M

-73.77%39.08M

3,244.31%148.99M

-16.42%134.88M

917.57%118.8M

Current changes in cash

-137.05%-12.64M

-83.15%-9.11M

121.72%23.87M

93.83%-5.92M

-96.01%641K

408.80%34.12M

74.02%-4.97M

-176.04%-109.91M

-673.42%-95.8M

-89.26%16.08M

End cash Position

-39.61%41.2M

57.85%53.84M

61.07%62.95M

-48.94%68.87M

-42.57%68.23M

-73.73%34.11M

-73.77%39.08M

-16.42%134.88M

Free cash flow

44.41%-9.7M

10.08%-20.39M

-27.06%-63.64M

8.15%-10.46M

-57.27%-13.05M

-59.17%-17.45M

-16.67%-22.68M

-122.90%-50.08M

8.71%-11.39M

52.24%-8.3M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	45.36%-9.16M	7.78%-19.65M	-20.19%-59.66M	14.73%-9.64M	-45.83%-11.95M	-56.32%-16.76M	-9.76%-21.31M	-121.38%-49.64M	9.00%-11.31M	52.83%-8.2M
Net income from continuing operations	18.85%-14.58M	-20.14%-18.29M	-8.68%-65.77M	-16.93%-16.27M	-12.63%-16.3M	1.63%-17.97M	-9.86%-15.22M	45.03%-60.51M	12.99%-13.91M	83.38%-14.47M
Depreciation and amortization	13.95%49K	31.58%50K	6.29%169K	-4.35%44K	266.67%44K	59.26%43K	-48.65%38K	51.43%159K	-36.11%46K	-58.62%12K
Other non cash items	0.00%115K	-0.57%173K	35.86%519K	2.68%115K	5,850.00%115K	-22.30%115K	40.32%174K	-54.31%382K	-5.88%112K	-101.13%-2K
Change In working capital	347.14%2.81M	39.35%-4.75M	-87.03%-3.4M	499.22%3.84M	-52.72%1.73M	-180.35%-1.14M	-4.01%-7.84M	-114.86%-1.82M	-67.76%641K	174.47%3.66M
-Change in receivables	-152.25%-987K	114.99%555K	-94.74%-3.63M	-42.61%229K	-930.81%-2.04M	192.87%1.89M	-36.74%-3.7M	-113.16%-1.86M	--399K	---198K
-Change in inventory	-127.93%-162K	125.23%490K	-75.44%-3.27M	-97.43%-2.23M	4,700.00%322K	210.48%580K	-861.39%-1.94M	---1.86M	---1.13M	---7K
-Change in prepaid assets	-0.87%1.47M	248.44%953K	346.27%3.6M	794.78%1.03M	264.04%1.73M	2,603.64%1.49M	-10.88%-642K	32.46%-1.46M	107.01%115K	-153.98%-1.05M
-Change in payables and accrued expense	148.73%2.5M	-338.08%-6.76M	-104.10%-132K	269.53%4.82M	-65.73%1.72M	-603.54%-5.13M	62.61%-1.54M	-61.16%3.22M	-62.01%1.3M	38.25%5.03M
-Change in other current assets	-27.67%115K	18.97%138K	18.54%518K	66.67%120K	51.85%123K	0.00%159K	-7.20%116K	-9.15%437K	41.18%72K	-81.16%81K
-Change in other current liabilities	-1.59%-128K	-1.61%-126K	-72.51%-502K	-4.96%-127K	33.86%-125K	-300.00%-126K	-181.82%-124K	96.58%-291K	-182.31%-121K	97.79%-189K
Cash from discontinued investing activities
Operating cash flow	45.36%-9.16M	7.78%-19.65M	-20.19%-59.66M	14.73%-9.64M	-45.83%-11.95M	-56.32%-16.76M	-9.76%-21.31M	-121.38%-49.64M	9.00%-11.31M	52.83%-8.2M
Investing cash flow
Cash flow from continuing investing activities	-107.06%-3.57M	-35.36%10.56M	162.61%83.21M	104.32%3.65M	126.26%12.67M	21,079.67%50.56M	71,095.65%16.33M	-628.31%-132.89M	-183,332.61%-84.38M	-290.26%-48.24M
Net PPE purchase and sale	21.48%-541K	46.02%-739K	-794.59%-3.97M	-946.15%-816K	-976.47%-1.1M	-185.89%-689K	-5,852.17%-1.37M	-865.22%-444K	-69.57%-78K	---102K
Net investment purchase and sale	-105.91%-3.03M	-36.18%11.29M	165.82%87.18M	105.30%4.47M	128.59%13.77M	--51.25M	--17.7M	---132.44M	---84.3M	---48.14M
Cash from discontinued investing activities
Investing cash flow	-107.06%-3.57M	-35.36%10.56M	162.61%83.21M	104.32%3.65M	126.26%12.67M	21,079.67%50.56M	71,095.65%16.33M	-628.31%-132.89M	-183,332.61%-84.38M	-290.26%-48.24M
Financing cash flow
Cash flow from continuing financing activities	-72.20%87K	-225.00%-10K	-99.55%326K	174.77%80K	-100.10%-75K	459.77%313K	-97.32%8K	-48.79%72.62M	-221.59%-107K	-48.83%72.52M
Net common stock issuance	----	----	--0	--0	----	----	----	-53.23%72.5M	--0	----
Proceeds from stock option exercised by employees	-74.03%94K	--0	-37.61%486K	-65.35%114K	-87.50%2K	166.18%362K	-97.32%8K	-6.48%779K	273.86%329K	-97.85%16K
Net other financing activities	---7K	---10K	75.72%-160K	92.20%-34K	---77K	----	----	93.15%-659K	---436K	--0
Cash from discontinued financing activities
Financing cash flow	-72.20%87K	-225.00%-10K	-99.55%326K	174.77%80K	-100.10%-75K	459.77%313K	-97.32%8K	-48.79%72.62M	-221.59%-107K	-48.83%72.52M
Net cash flow
Beginning cash position	57.85%53.84M	61.07%62.95M	-73.77%39.08M	-48.94%68.87M	-42.57%68.23M	-73.73%34.11M	-73.77%39.08M	3,244.31%148.99M	-16.42%134.88M	917.57%118.8M
Current changes in cash	-137.05%-12.64M	-83.15%-9.11M	121.72%23.87M	93.83%-5.92M	-96.01%641K	408.80%34.12M	74.02%-4.97M	-176.04%-109.91M	-673.42%-95.8M	-89.26%16.08M
End cash Position	-39.61%41.2M	57.85%53.84M	61.07%62.95M	61.07%62.95M	-48.94%68.87M	-42.57%68.23M	-73.73%34.11M	-73.77%39.08M	-73.77%39.08M	-16.42%134.88M
Free cash flow	44.41%-9.7M	10.08%-20.39M	-27.06%-63.64M	8.15%-10.46M	-57.27%-13.05M	-59.17%-17.45M	-16.67%-22.68M	-122.90%-50.08M	8.71%-11.39M	52.24%-8.3M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data